MapLight Insider Jonathan Gillis Sold 69,835 Shares for $2.09 Million in April 2026
MapLight Therapeutics' Chief Administrative and Accounting Officer, Jonathan Gillis, sold 69,835 shares of the company's stock for approximately $2.09 million in late April 2026. The sale reduced his direct holdings by 27.8%, and the transaction was executed through open-market transactions. The sale is the largest direct insider transaction by Gillis in the past year.
Topics: executive activity insider trading SEC filing stock sales